比亞迪:「仰望U9」售價168萬人幣 漢、唐將推榮耀版即將上市
比亞迪(01211.HK)(002594.SZ)旗下高端品牌仰望第二款車型仰望U9上市,售價168萬元人民幣,將在年中正式啟動交付。
仰望U9搭載易四方U型電機,官方稱搭配旋變傳感器後,識別精度、響應速度將遠高於傳統超跑。仰望在發布會上表示,U9可實現極速 309.19km/h,0-100km/h加速 2.36 秒,0-400 米衝刺 9.78 秒,且擁有不限次數的彈射能力。
同時,比亞迪汽車宣布,比亞迪漢、比亞迪唐將推出榮耀版,新車上市發布會定於周三(28日)下午三時舉行。(ta/w)
~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.